Themis Medicare Stock Screener | Share Price & Fundamental Analysis
THEMISMED
Pharmaceuticals
Share Price NSE
₹81.83
▲
3.33 (4.24%)
Share Price BSE
₹82.79
▲
3.19 (4.01%)
Track Themis Medicare share price live with TickJournal's free stock screener.
Analyze Themis Medicare share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Themis Medicare Market Cap
₹729.62 Cr.
THEMISMED P/E Ratio (TTM)
-39.08
Themis Medicare P/B Ratio
1.96
EPS (TTM)
₹3.24
Dividend Yield
0.68%
Debt to Equity
0.25
THEMISMED 52 Week High
₹170.74
Themis Medicare 52 Week Low
₹66.07
Operating Margin
10.00%
Profit Margin
10.31%
THEMISMED Revenue (TTM)
₹97.00
EBITDA
₹16.00
Net Income
₹10.00
Total Assets
₹588.00
Total Equity
₹403.00
Themis Medicare Share Price History - Stock Screener Chart
Screen THEMISMED historical share price movements with interactive charts. Analyze price trends and patterns.
Themis Medicare Company Profile - Fundamental Screener
Screen Themis Medicare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for THEMISMED shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE083B01024
Themis Medicare Balance Sheet Screener
Screen THEMISMED balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 588 | 566 | 514 | 428 | 371 | 350 | 314 | 305 | 289 | 275 |
| Current Assets | 304 | 293 | 265 | 214 | 186 | 181 | 150 | 143 | 124 | 133 |
| Fixed Assets | 172 | 168 | 162 | 144 | 133 | 116 | 123 | 126 | 124 | 117 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 29 | 36 | 35 | 31 | 24 | 12 | 9 | 12 | 12 | 71 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 403 | 378 | 339 | 288 | 219 | 183 | 158 | 169 | 152 | 74 |
| Share Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves & Surplus | 393 | 369 | 330 | 278 | 209 | 174 | 149 | 160 | 143 | 66 |
Themis Medicare Income Statement Screener - Profit & Revenue Analysis
Screen Themis Medicare income statement and profit fundamentals.
Analyze THEMISMED quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Themis Medicare share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 97 | 83 | 99 | 73 | 95 | 123 | 130 | 103 | 89 | 111 | 103 | 85 | 84 | 101 | 97 |
| Expenses | 81 | 81 | 108 | 79 | 88 | 100 | 94 | 89 | 74 | 92 | 75 | 70 | 65 | 74 | 70 |
| EBITDA | 16 | 2 | -9 | -6 | 7 | 23 | 36 | 14 | 14 | 19 | 28 | 16 | 19 | 27 | 28 |
| Operating Profit % | 10.00% | -4.00% | -10.00% | -11.00% | 6.00% | 15.00% | 24.00% | 10.00% | 10.00% | 12.00% | 22.00% | 13.00% | 18.00% | 22.00% | 23.00% |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 |
| Interest | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 2 | 2 | 2 |
| Profit Before Tax | 10 | -4 | -14 | -11 | 2 | 18 | 31 | 9 | 8 | 14 | 23 | 10 | 14 | 22 | 23 |
| Tax | 0 | 0 | 0 | -2 | 1 | 4 | 7 | 2 | 1 | 3 | 4 | 2 | 4 | 5 | 5 |
| Net Profit | 10 | -4 | -14 | -10 | 1 | 14 | 25 | 7 | 7 | 11 | 18 | 8 | 10 | 17 | 18 |
| EPS | 1.10 | -0.39 | -1.54 | -1.05 | 0.06 | 1.55 | 2.68 | 0.72 | 0.80 | 12.30 | 19.77 | 9.13 | 10.81 | 18.92 | 19.33 |
Themis Medicare Cash Flow Screener - Liquidity Fundamentals
Screen THEMISMED cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 35 | 22 | 16 | 34 | 57 | 0 | 11 | 8 | -2 | 26 |
| Investing Activities | -12 | -16 | -24 | -16 | -16 | -6 | -4 | 0 | -4 | -7 |
| Financing Activities | -26 | -9 | 0 | -18 | -26 | 7 | -10 | -9 | 5 | -13 |
| Net Cash Flow | -3 | -3 | -8 | 1 | 16 | 2 | -3 | -1 | 0 | 5 |
Themis Medicare Shareholding Pattern Screener
See Themis Medicare shareholding pattern with promoter, FII, and DII holdings.
Check Themis Medicare promoter holding and ownership changes for THEMISMED on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 67.15% | 67.15% | 67.15% | 67.11% | 67.15% | 67.15% | 67.15% | 67.15% |
| FII Holding | 0.14% | 0.10% | 0.06% | 0.05% | 0.03% | 0.05% | 0.10% | 0.10% |
| DII Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.93% | 24.14% | 23.97% | 24.02% | 23.31% | 23.42% | 23.65% | 24.24% |
| Other Holding | 8.77% | 8.60% | 8.80% | 8.81% | 9.49% | 9.37% | 9.09% | 8.50% |
| Shareholder Count | 17,889 | 19,335 | 22,490 | 22,576 | 11,295 | 11,322 | 14,270 | 17,773 |
Themis Medicare Share Dividend Screener - Share Yield Analysis
Check Themis Medicare dividend history with payout and yield data.
View Themis Medicare dividend details including ex-dates and amounts for THEMISMED stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.50 | 0.76% |
| 2024-March | ₹0.50 | 0.34% |
| 2023-March | ₹5.00 | 2.29% |
| 2022-March | ₹5.00 | 4.24% |
| 2021-March | ₹4.30 | 4.59% |
| 2020-March | ₹1.75 | 6.22% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Themis Medicare Stock Index Membership
See which indices include Themis Medicare stock.
Check THEMISMED index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX SMLCAP
Themis Medicare Market Events Screener - Corporate Actions
Get Themis Medicare corporate actions including splits, bonuses, and buybacks.
Check Themis Medicare stock events that may affect THEMISMED share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.50 /share | -41.32% | ||
| Dividend | ₹ 5.00 /share | 5.80% | ||
| Dividend | ₹ 5.00 /share | 2.89% | ||
| Dividend | ₹ 4.30 /share | 77.77% | ||
| Annual General Meeting | NA | -1.60% | ||
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 7.49% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -1.41% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | -8.21% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 25.64% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -15.07% |
| 2024-10-25 | 2024-10-25 | Quarterly Result Announcement | NA | 1.15% |
| 2024-07-22 | 2024-07-22 | Annual General Meeting | NA | 5.80% |
| 2024-07-12 | 2024-07-15 | Dividend | ₹ 0.50 /share | 9.31% |
| 2023-10-10 | 2023-05-13 | Split | 1:10 | 0.00% |
Themis Medicare Competitors Screener - Peer Comparison
Screen THEMISMED competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 406,351 | 37.86 | 54,729 | 9.71% | 10,980 | 37.98 |
| Divis Laboratories | 155,472 | 63.26 | 9,712 | 18.67% | 2,191 | 33.24 |
| Torrent Pharmaceuticals | 134,945 | 61.20 | 11,539 | 6.99% | 1,911 | 32.75 |
| Lupin | 103,954 | 22.26 | 22,910 | 13.74% | 3,306 | 47.35 |
| Dr Reddys Laboratories | 101,601 | 18.27 | 33,741 | 16.73% | 5,725 | 39.36 |
| Cipla | 96,320 | 21.31 | 28,410 | 7.12% | 5,291 | 26.86 |
| Zydus Life Science | 86,964 | 17.29 | 23,511 | 18.55% | 4,615 | 41.42 |
| Mankind Pharma | 82,499 | 45.81 | 12,744 | 20.90% | 2,007 | 41.40 |
| Aurobindo Pharma | 77,462 | 22.37 | 32,346 | 9.43% | 3,484 | 64.38 |
| Alkem Laboratories | 62,867 | 25.87 | 13,458 | 3.70% | 2,216 | 42.54 |
Themis Medicare Company Announcements - News Screener
Screen THEMISMED latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-02 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-04-02 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-04-02 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-04-02 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-31 | Announcement Under Regulation 30 (LODR) - Updates | - |
| 2026-03-24 | Closure of Trading Window | - |
| 2026-03-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-03-10 | Corrigendum To The Notice Of Postal Ballot Dated 25Th February 2026. | - |
| 2026-03-10 | Disclosure Of The Preferential Issue Committee Meeting Under Regulation 30 | - |
| 2026-02-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-25 | Disclosure Of The Preferential Issue Committee Meeting Under Regulation 30 | - |
| 2026-02-25 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-02-13 | Results - Financial Results For The Quarter And Nine Months Ended 31St December 2025 | - |
| 2026-02-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On 13/02/2026 | - |
| 2026-02-10 | Update on board meeting | - |
| 2026-02-06 | Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2025. | - |